Sell Cochlear says Goldman Sachs in analysis release to market

MELBOURNE: Equity analysts at Goldman Sachs say hearing implant maker Cochlear is a ... read more

NSW to fund RNA pilot facility to develop vaccines

SYDNEY: The NSW government will fund a $96 million facility to develop mRNA ... read more

Telix inching towards approvals for flagship cancer drug

MELBOURNE: Cancer drug developer Telix has told investors that if the US regulator ... read more

Healius booms as test demand continues to grow

MELBOURNE: Pathology tester Healius is eyeing PCR testing for international travellers, after revealing ... read more